Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters
Language
Document Type
Year range
1.
Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.
Bosserman, Rachel E; Farnsworth, Christopher W; O'Neil, Caroline A; Cass, Candice; Park, Daniel; Ballman, Claire; Wallace, Meghan A; Struttmann, Emily; Stewart, Henry; Arter, Olivia; Peacock, Kate; Fraser, Victoria J; Budge, Philip J; Olsen, Margaret A; Burnham, Carey-Ann D; Babcock, Hilary M; Kwon, Jennie H.
Antimicrob Steward Healthc Epidemiol ; 2(1): e93, 2022.
Article in English | MEDLINE | ID: covidwho-20233422

ABSTRACT

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.

2.
Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
Bosserman, Rachel E.; Farnsworth, Christopher W.; O’Neil, Caroline A.; Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A.; Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J.; Budge, Philip J.; Olsen, Margaret A.; Burnham, Carey-Ann D.; Babcock, Hilary M.; Kwon, Jennie H..
Antimicrobial stewardship & healthcare epidemiology : ASHE ; 2(1), 2022.
Article in English | EuropePMC | ID: covidwho-2147131

ABSTRACT

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14–28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70–180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL